, Volume 37, Issue 2, pp 147–152

Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound

  • James C. Russell
  • H. Stephen Ewart
  • Sandra E. Kelly
  • Jaroslav Kralovec
  • Jeffrey L. C. Wright
  • Peter J. Dolphin


The syndrome that is characterized by obesity, insulin resistance, and hyperlipidemia is increasingly prevalent in all prosperous societies. It is now recognized as a major contributor to cardiovascular disease. Vascular dysfunction in the form of hypercontractility and impaired nitric oxide-mediated relaxation is a significant component of cardiovascular disease, predisposing to ischemic events. The JCR:LA-cp strain of rats exhibits all major aspects of the obesity/insulin resistance syndrome, including vascular dysfunction and ischemic lesions of the heart. Dietary lipid intake may have a marked effect on plasma lipid levels and, potentially, on vascular disease. We have investigated the effects of a novel preparation, ONC101 (a phytosterol esterified with fish oil), on plasma lipids and vascular function in the insulin-resistant JCR:LA-cp rat. Treatment of obese male rats with ONC101 from 8 to 12 wk of age resulted in no change in plasma lipid concentrations at 0.5 g/kg body weight. At the higher dose of 2.6 g/kg, plasma TG fell 50% (1.26 vs. 2.59 mmol/L, P<0.002) and cholesterol esters were significantly reduced (1.34 vs. 1.61 mmol/l, P<0.002). Food intake and body weights were unaffected by ONC101 treatment. At the low dose of 86 mg/kg, the hypercontractility of aortic rings in response to phenylephrine was normalized and the relaxant response to acetylcholine was significantly improved. The results indicate that ONC101 at high doses has significant hypolipidemic effects and, at very low doses, has beneficial effects on endothelial and vascular smooth muscle cell function.





NG-nitro-l-arginine methyl ester


nitric oxide




very low density lipoprotein


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eisenberg, D. (1998) The Importance of Lowering Cholesterol in Patients with Coronary Heart Disease, Clin. Cardiol. 21, 81–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Hulthe, J., Bokemark, L., Wikstrand, J., and Fagerberg, B. (2000) The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) Study, Atheroscler. Thromb. Vasc. Biol. 20, 2140–2147.Google Scholar
  3. 3.
    Grundy, S.M. (1998) Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome (review), Am. J. Cardiol. 81, 18B-25B.PubMedCrossRefGoogle Scholar
  4. 4.
    Gotto, A.M., Jr. (1998) Triglyceride: The Forgotten Risk Factor, Circulation 97, 1027–1028.PubMedGoogle Scholar
  5. 5.
    Jeppeson, J., Hein, O.H., Suadicani, P., and Gyntelberg, F. (1998) Triglyceride Concentration and Ischemic Heart Disease: An Eight-Year Follow-Up in the Copenhagen Male Study, Circulation 97, 1029–1036.Google Scholar
  6. 6.
    Després, J.P. (1998) The Insulin Resistance-Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients’ Risk, Obesity Res. 6 (Suppl. 1), 8S-17S.Google Scholar
  7. 7.
    Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G.R., Moorjani, S., and Lupien, P.J. (1996) Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease, N. Engl. J. Med. 334, 952–957.PubMedCrossRefGoogle Scholar
  8. 8.
    Russell, J.C., Bar-Tana, J., Shillabeer, G., Lau, D.C.W., Richardson, M., Wenzel, L.M., Graham, S.E., and Dolphin, P.J. (1998) Development of Insulin Resistance in the JCR:LA-cp Rat: Role of Triacylglycerols and Effects of MEDICA 16, Diabetes 47, 770–778.PubMedGoogle Scholar
  9. 9.
    GISSI-Prevenzione Investigators. (1999) Dietary Supplementation with n−3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial, Lancet 354, 447–455.CrossRefGoogle Scholar
  10. 10.
    Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetman, P.M., Elwood, P.C., and Deadman, N.M. (1989) Effects of Changes in Fat, Fish, and Fibre Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART), Lancet 30, 757–761.CrossRefGoogle Scholar
  11. 11.
    Singh, R.B., Sharma, J.P., Kumar, R., Rastogi, V., and Moshiri, M. (1997) Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival, Cardiovasc. Drugs Ther. 11, 485–491.PubMedCrossRefGoogle Scholar
  12. 12.
    Leaf, A., Kang, J.X., Xiao, Y.-F., and Billman, G.E. (1999) n−3 Fatty Acids in the Prevention of Cardiac Arrhythmias, Lipids 34 (Suppl.), S187-S189.PubMedGoogle Scholar
  13. 13.
    Murphy, M.G., Wright, V., Scott, J., Timmins, A., and Ackman, R.G. (1999) Dietary Menhaden, Seal, and Corn Oils Differentially Affect Lipid and ex vivo Eicosanoid and Thiobarbituric Acid-Reactive Substances Generation in the Guinea Pig, Lipids 34, 115–124.PubMedCrossRefGoogle Scholar
  14. 14.
    Harris, W.S. (1989) Fish Oils and Plasma Lipid and Lipoprotein Metabolism in Humans: A Critical Review, J. Lipid Res. 30, 785–807.PubMedGoogle Scholar
  15. 15.
    Jones, P.J.H., MacDougall, D.E., Ntanios, F., and Vanstone, C.A. (1997) Dietary Phytosterols as Cholesterol-Lowering Agents in Humans, Can. J. Physiol. Pharmacol. 75, 217–227.PubMedCrossRefGoogle Scholar
  16. 16.
    Ling, W.H., and Jones, P.J.H. (1995) Dietary Phytosterols: A Review of Metabolism, Benefits and Side Effects, Life Sci. 57, 195–206.PubMedCrossRefGoogle Scholar
  17. 17.
    Heinemann, T., Kullak-Ublick, G.A., Pietruck, B., and von Bergmann, K. (1991) Mechanisms of Action of Plant Sterols on Inhibition of Cholesterol Absorption: Comparison of Sitosterol and Sitostanol, Eur. J. Clin. Pharmacol. 40 (Suppl. 1), S59-S63.PubMedCrossRefGoogle Scholar
  18. 18.
    Miettinen, T.A., Puska, P., Gylling, H., Vanhanen, H., and Vartiainen, E. (1995) Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population, N. Engl. J. Med. 333, 1308–1312.PubMedCrossRefGoogle Scholar
  19. 19.
    Richardson, M., Schmidt, A.M., Graham, S.E., Achen, B., DeReske, M., and Russell, J.C. (1998) Vasculopathy and Insulin Resistance in the JCR:LA-cp Rat, Atherosclerosis 138, 135–146.PubMedCrossRefGoogle Scholar
  20. 20.
    Russell, J.C., Koeslag, D.G., Amy, R.M., and Dolphin, P.J. (1989) Plasma Lipid Secretion and Clearance in the Hyperlipidemic JCR:LA-Corpulent Rat, Arteriosclerosis 9, 869–876.PubMedGoogle Scholar
  21. 21.
    Vance, J.E., and Russell, J.C. (1990) Hypersecretion of VLDL, but Not HDL, by Hepatocytes from the JCR:LA-Corpulent Rat, J. Lipid Res. 31, 1491–1501.PubMedGoogle Scholar
  22. 22.
    Russell, J.C., Ravel, D., Pégorier, J.-P., Delrat, P., Jochemsen, R., O’Brien, S.F., Kelly, S.E., Davidge, S.T., and Brindley, D.N. (2000) Beneficial Insulin-Sensitizing and Vascular Effects of S15261 in the Insulin-Resistant JCR:LA-cp Rat, J. Pharmacol. Exp. Ther. 295, 753–760.PubMedGoogle Scholar
  23. 23.
    Russell, J.C., McKendrick, J.D., Dubé, G.P., Dolphin, P.J., and Radomski, M.W. (2001) Effects of LY117018 and the Estrogen Analogue, 17-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric Oxide, J. Cardiovasc. Pharmacol. 37, 119–128.PubMedCrossRefGoogle Scholar
  24. 24.
    Dolphin, P.J., Amy, R.M., Koeslag, D.G., Limoges, B.F., and Russell, J.C. (1988) Reduction of Hyperlipidemia in the LA/N-Corpulent Rat by Dietary Fish Oil Containing n−3 Fatty Acids, Biochim. Biophys. Acta 962, 317–329.PubMedGoogle Scholar
  25. 25.
    Russell, J.C., Amy, R.M., and Dolphin, P.J. (1991) Effect of n−3 Fatty Acids on Atherosclerosis Prone JCR:LA-Corpulent Rats, Exp. Mol. Pathol. 55, 285–293.PubMedCrossRefGoogle Scholar
  26. 26.
    Ratnayake, W.M.N., Plouffe, L., Hollywood, R., L’Abbé, M.R., Nidiroglou, N., Sarwar, G., and Mueller, R. (2000) Influence of Sources of Dietary Oils on the Life Span of Stroke-Prone Spontaneously Hypertensive Rats, Lipids 35, 409–419.PubMedCrossRefGoogle Scholar
  27. 27.
    Russell, J.C., Amy, R.M., Graham, S.E., Dolphin, P.J., Wood, G.O., and Bar-Tana, J. (1995) Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by β,β′-Tetramethylhexadecanedioic Acid (MEDICA 16), Arterioscler. Thromb. Vasc. Biol. 15, 918–923.PubMedGoogle Scholar
  28. 28.
    Russell, J.C., Graham, S.E., and Dolphin, P.J. (1999) Glucose Tolerance and Insulin Resistance in the JCR:LA-cp Rat: Effect of Miglitol (Bay m1099), Metabolism 48, 701–706.PubMedCrossRefGoogle Scholar
  29. 29.
    O’Brien, S.F., McKendrick, J.D., Radomski, M.W., Davidge, S.T., and Russell, J.C. (1998) Vascular Wall Reactivity in Conductance and Resistance Arteries: Differential Effects of Insulin Resistance, Can. J. Physiol. Pharmacol. 76, 72–76.PubMedCrossRefGoogle Scholar
  30. 30.
    Kuksis, A., Myher, J.J., Geher, K., Hoffman, A.G., Breckenridge, W.C., Jones, G.J., and Little, J.A. (1978) Comparative Determination of Plasma Cholesterol and Triacylglycerol Levels by Automated Gas-Liquid Chromatographic and Autoanalyzer Techniques, J. Chromatogr. 146, 393–412.PubMedGoogle Scholar
  31. 31.
    De Lean, A., Munson, P.J., Guardabaso, V., and Rodbard, D. (1992) A Users’ Guide to ALLFIT, National Institutes of Health, Bethesda.Google Scholar
  32. 32.
    Absher, P.M., Schneider, D.J., Russell, J.C., and Sobel, B.E. (1997) Increased Proliferation of Explanted Vascular Smooth Muscle Cells: A Marker Presaging Atherogenesis, Atherosclerosis 131, 187–194.PubMedCrossRefGoogle Scholar
  33. 33.
    Absher, P.M., Schneider, D.J., Baldor, L.C., Russell, J.C., and Sobel, B.E. (1999) The Retardation of Vasculopathy Induced by Attenuation of Insulin Resistance in the Corpulent JCR:LA-cp Rat Is Reflected by Decreased Vascular Smooth Muscle Cell Proliferation in vivo, Atherosclerosis 143, 245–251.PubMedCrossRefGoogle Scholar
  34. 34.
    Tagawa, H., Shimokawa, H., Tagawa, T., Kuroiwa-Matsumoto, M., Hirooka, Y., and Takeshita, A. (1999) Long-Term Treatment with Eicosapentaenoic Acid Augments Both Nitric Oxide-Mediated and Non-Nitric Oxide Mediated Endothelium-Dependent Forearm Vasodilation in Patients with Coronary Artery Disease, J. Cardiovasc. Pharmacol. 33, 633–640.PubMedCrossRefGoogle Scholar
  35. 35.
    Goodfellow, J., Bellamy, M.F., Ramsey, M.W., Jones, C.J.H., and Lewis, M.J. (2000) Dietary Supplementation with Marine Omega-3 Fatty Acids Improve Systemic Large Artery Endothelial Function in Subjects with Hypercholesterolemia, J. Am. Coll. Cardiol. 35, 265–270.PubMedCrossRefGoogle Scholar
  36. 36.
    O’Brien, S.F., and Russell, J.C. (1997) Insulin Resistance and Vascular Wall Function: Lessons from Animal Models (review), Endocrinol. Metab. 4, 155–162.Google Scholar
  37. 37.
    Schneider, D.J., Absher, P.M., Neimane, D., Russell, J.C., and Sobel, B.E. (1998) Fibrinolysis and Atherogenesis in the JCR:LA-cp Rat in Relation to Insulin and Triglyceride Concentrations in Blood, Diabetologia 41, 141–147.PubMedCrossRefGoogle Scholar

Copyright information

© AOCS Press 2002

Authors and Affiliations

  • James C. Russell
    • 3
  • H. Stephen Ewart
    • 1
  • Sandra E. Kelly
    • 3
  • Jaroslav Kralovec
    • 1
  • Jeffrey L. C. Wright
    • 1
  • Peter J. Dolphin
    • 2
  1. 1.Ocean Nutrition Canada Ltd.Halifax
  2. 2.Department of BiochemistryDalhousie UniversityHalifaxCanada
  3. 3.Department of Surgery, 275 Heritage Medical Research CentreUniversity of AlbertaEdmontonCanada

Personalised recommendations